Teda Biotech announces 2023 performance, with shareholders' net loss of 20.16 million yuan, a year-on-year decrease of 26.56%
智通財經 APP 訊，泰達生物公佈 2023 年業績，營業額約 3.98 億元，同比減少 1.42%;股東應占虧損 2016 萬元，同比收窄 26.56%;每股虧損 1.06 分。
智通財經 APP 訊，泰達生物 (08189) 公佈 2023 年業績，營業額約 3.98 億元，同比減少 1.42%;股東應占虧損 2016 萬元，同比收窄 26.56%;每股虧損 1.06 分。
Source: 智通財經 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments